Korshun L N, Moĭsa L N, Ganova L A, Vudmaska M I, Kovtoniuk G V, Kiseleva E K, Spivak N Ia
Mikrobiol Z. 2011 Sep-Oct;73(5):36-46.
It is shown that the recombinant protein GST-HSV2gG, containing the immunodominant regions of glycoprotein G of HSV-2 is accumulated in the form of inclusion bodies or in soluble form in the Escherichia coli BL21 (DE3) cells. The ratio between protein fractions varied depending on the physiological state of cells before biosynthesis. The kinetic parameters of bacterial populations were determined by mathematical modeling of growth curves based on the Verhulst logistic function. It was established that the induction of biosynthesis in the growth acceleration phase (at OD600 = 0.3) with 0.1 mM IPTG gives the maximum yield of soluble protein (26.75 mg/l or 17.6 mg/g biomass). The target protein was purified using the immobilized metal ion affinity and affinity chromatography technologies. Antigenic activity of the soluble form of recombinant protein GST-HSV2gG, was significantly (three times) higher than that of the protein purified from inclusion bodies (p < 0.05) and was comparable with the activity of the commercial analog (p > 0.05), that allows using this product in the immunosorbent test kits for diagnosis of IgG to HSV-2.
结果表明,含有单纯疱疹病毒2型(HSV - 2)糖蛋白G免疫显性区域的重组蛋白GST - HSV2gG,以包涵体形式或可溶性形式在大肠杆菌BL21(DE3)细胞中积累。蛋白质组分之间的比例因生物合成前细胞的生理状态而异。基于Verhulst逻辑函数对生长曲线进行数学建模,确定了细菌群体的动力学参数。已确定,在生长加速期(OD600 = 0.3)用0.1 mM异丙基-β-D-硫代半乳糖苷(IPTG)诱导生物合成,可得到可溶性蛋白的最大产量(26.75 mg/l或17.6 mg/g生物量)。使用固定化金属离子亲和色谱和亲和色谱技术纯化目标蛋白。重组蛋白GST - HSV2gG可溶性形式的抗原活性显著高于(三倍)从包涵体中纯化的蛋白(p < 0.05),且与商业类似物的活性相当(p > 0.05),这使得该产品可用于免疫吸附试验试剂盒中检测HSV - 2的IgG。